title: Treatment of HIV-related inflammatory cerebral cryptococcoma with adalimumab.
abstract: Cryptococcomas have been described in AIDS patients in the setting of immune reconstitution inflammatory syndrome. We report the first case of human immunodeficiency virus-related inflammatory cerebral cryptococcoma to be treated with a recombinant human monoclonal tumor necrosis factor antagonist.
authors.affiliation: Departments of Medicine, University of California, San Diego School of Medicine, San Diego, USA. asitapati@ucsd.edu
authors.forename: Amy M
authors.initials: AM
authors.lastname: Sitapati
authors.forename: Cynthia L
authors.initials: CL
authors.lastname: Kao
authors.forename: Edward R
authors.initials: ER
authors.lastname: Cachay
authors.forename: Homeyra
authors.initials: H
authors.lastname: Masoumi
authors.forename: Robert S
authors.initials: RS
authors.lastname: Wallis
authors.forename: W Christopher
authors.initials: WC
authors.lastname: Mathews
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D016919:Meningitis, Cryptococcal / Q000188:drug therapy* / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab